In terms of DFS, high GPSM2 expression was associated with poor prognosis in ACC (p = 4.3e-03), LIHC (p = 1.3e-05), MESO (p = 4.6e-02), PAAD (p = 3.2e-03), and UVM (p = 3.8e-02) (Figure 4B). The gene discussed is GPSM2; the disease is adrenal cortex carcinoma.